CAS RN: 832720-36-2
Elagolix Sodium
Product Availability
Choose a grade to view its available package options.
5 package records5 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250125 |
1ml |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251208 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250418 |
1g |
In stock |
Shanghai | Inquiry |
| Batchno.20260227 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250421 |
5g |
In stock |
Shanghai | Inquiry |
-
Product code:
starshine_CAS832720-36-2
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
832720-36-2 / sodium 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
Standard CAS: 832720-36-2
Multi CAS: Yes
Basic Information
CAS
832720-36-2
Multi CAS
Yes
Molecular Formula
C32H29F5N3NAO5
Molecular Weight
653.600000
Exact Mass
653.192506
InChI
InChI=1S/C32H30F5N3O5.Na/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33;/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42);/q;+1/p-1/t25-;/m0./s1
InChIKey
DQYGXRQUFSRDCH-UQIIZPHYSA-M
Computed Properties
Structural Parameters
Heavy atom count
46
Aromatic heavy atom count
24
Fraction Csp3
0.28
Rotatable bonds
12
H-bond acceptors
8
H-bond donors
1
Molar refractivity
153.58
TPSA
105.39
LogP / Solubility
WLOGP
1.2
MLOGP
1.11
XLogP3
1.2
Consensus LogP
1.17
Log S (ESOL)
-4.25
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.79
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.35
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-5.85
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
No
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5